James M Henning
Overview
Explore the profile of James M Henning including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
940
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dubois R, Melmed G, Henning J, Bernal M
J Clin Rheumatol
. 2006 Oct;
10(4):178-89.
PMID: 17043507
Numerous studies using varying methodologies and outcome measures have examined the gastrointestinal risks of aspirin and nonaspirin nonsteroidal antiinflammatory drug (NSAID) use. Despite the large volume of literature, clarity regarding...
2.
Knight K, Badamgarav E, Henning J, Hasselblad V, Gano Jr A, Ofman J, et al.
Am J Manag Care
. 2005 Apr;
11(4):242-50.
PMID: 15839184
Objective: To systematically evaluate and synthesize published evidence regarding the effect of disease management programs for patients with diabetes mellitus on processes and outcomes of care. Study Design: Systematic literature...
3.
Borenstein J, Badamgarav E, Henning J, Gano Jr A, Weingarten S
Am J Med
. 2004 Sep;
117(5):297-304.
PMID: 15336578
Purpose: Little data are available to assess the efforts of managed care organizations to improve quality of care. This analysis assessed differences in performance rates between organizations with and without...
4.
Ofman J, Badamgarav E, Henning J, Knight K, Gano Jr A, Levan R, et al.
Am J Med
. 2004 Aug;
117(3):182-92.
PMID: 15300966
Purpose: To assess the clinical and economic effects of disease management in patients with chronic diseases. Methods: Electronic databases were searched for English-language articles from 1987 to 2001. Articles were...
5.
Dean B, Borenstein J, Henning J, Knight K, Merz C
Am Heart J
. 2004 Jun;
147(6):966-76.
PMID: 15199342
Background: The cardiovascular risk reduction observed in many trials of lipid-lowering agents is greater than expected on the basis of observed low-density lipoprotein cholesterol (LDL-C) level reductions. Our objective was...
6.
Ofman J, Badamgarav E, Henning J, Knight K, Laine L
Am J Med
. 2004 Jun;
116(12):835-42.
PMID: 15178499
Purpose: To describe patients initiating nonsteroidal anti-inflammatory drug (NSAID) therapy with regard to gastrointestinal and cardiac risks and patterns of antisecretory agent use, and to explore the relation between therapy...
7.
Cooperberg M, Broering J, Litwin M, Lubeck D, Mehta S, Henning J, et al.
J Urol
. 2004 Mar;
171(4):1393-401.
PMID: 15017184
Purpose: The epidemiology and treatment of prostate cancer have changed dramatically in the prostate specific antigen era. A large disease registry facilitates the longitudinal observation of trends in disease presentation,...
8.
Badamgarav E, Weingarten S, Henning J, Knight K, Hasselblad V, Gano Jr A, et al.
Am J Psychiatry
. 2003 Nov;
160(12):2080-90.
PMID: 14638573
Objective: The authors systematically evaluated the published evidence to assess the effectiveness of disease management programs in depression. Method: English-language articles on depression were identified through a MEDLINE search for...
9.
Majumdar S, Soumerai S, Farraye F, Lee M, Kemp J, Henning J, et al.
Am J Gastroenterol
. 2003 Nov;
98(11):2409-14.
PMID: 14638341
Objectives: The aims of this study were as follows: to establish the prevalence of chronic acid-related disorders in a managed care population; to describe these patients; and to examine rates...
10.
Ofman J, Sullivan S, Neumann P, Chiou C, Henning J, Wade S, et al.
J Manag Care Pharm
. 2003 Nov;
9(1):53-61.
PMID: 14613362
Objective: To examine the increasing use of health economic studies and practical implications of evaluating their quality utilizing the Quality of Health Economic Studies (QHES) instrument. Methods: We first reviewed...